VEXT — Vext Science Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$61.36m
- CA$108.95m
- $34.81m
- 47
- 69
- 45
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.79 | 2.13 | 4.99 | 10.9 | 4.4 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.351 | 1.39 | 3.31 | -0.233 | -13.6 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.64 | -3.07 | -1.74 | -7.18 | 7.04 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.393 | 3.1 | 11.7 | 5.72 | 4.42 |
Capital Expenditures | -5.26 | -4.06 | -18.8 | -8.86 | -2.74 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.147 | -8.84 | -8.31 | -21.5 | -2.09 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5.41 | -12.9 | -27.1 | -30.3 | -4.82 |
Financing Cash Flow Items | 0.145 | -0.5 | -1.5 | -1.63 | -1.03 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 9.7 | 4.26 | 20.1 | 24.1 | 3.19 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.9 | -5.55 | 4.72 | -0.533 | 2.79 |